TechTalk

TechTalkblog

InvestmentNews takes advisers through the developments and innovations in technology that'll change the way you do business today and tomorrow.

Wealthcare, UBS settle infringement suit

No terms disclosed in resolution of lawsuit filed in August 2011

Nov 8, 2012 @ 3:06 pm

By Davis Janowski

This just in; a minimalist prepared statement stating that Wealthcare Capital Management, Inc., Wealthcare Capital Management IP, LLC, UBS Financial Services Inc., and PIEtech, Inc. have settled a patent infringement suit.

The patent infringement lawsuit had been brought by Wealthcare and “any payment terms and other terms of the settlement are confidential.”

The lawsuit was filed by Wealthcare in August 2011 for infringement of its U.S. Patent Nos. 7,765,138 and 7,991,675 by UBS for use of systems that included PIEtech's MoneyGuidePro software.

PIEtech joined in the suit and both PIEtech and UBS denied liability and brought counterclaims of invalidity and non-infringement. The lawsuit was pending in the U.S. District Court for the Southern District of New York.

Soon after filing the suit Wealthcare Capital Management founder David B. Loeper said in an interview with InvestmentNews that the firm was simply defending the $17-million investment in its own intellectual capital spent over the years developing its own systems.

In a brief interview following the statement’s distribution Mr. Loeper reaffirmed that he could not comment on anything related to the suit.

“The terms and conditions of the settlement itself are confidential but I can say that our patents still stand and in the end they remain valid,” he said.

UBS and PIEtech representatives did not respond to requests for comment.

Related stories

Financeware sues UBS and makers of MoneyGuidePro for patent infringement

About David Loeper

0
Comments

What do you think?

View comments

Recommended for you

Featured Research

The 2015 InvestmentNews Adviser Technology Study

This in-depth study provides a blueprint for the industry, providing actionable information to advisers, along with the latest solutions to help them drive profitability, efficiency and growth for their firm.

Featured video

INTV

Why broker-dealers are on a roll

Deputy editor Bob Hordt and senior columnist Bruce Kelly discuss last year's bounce-back for IBDs.

Latest news & opinion

Things are looking up: IBDs soared in 2017

With revenue up, interest rates rising and regulation easing, IBDs are soaring.

SEC advice rule may give RIAs leg up over broker-dealers

Experts say advisers will be able to point to their role as fiduciaries as a differentiator in the advice market.

Brokers accept proposed SEC rule on who can call themselves an adviser

Some say the rule will clear up investor confusion, but others say the SEC didn't go far enough.

SEC advice rule: Here's what you need to know

We sifted through the nearly 1,000-page proposal and picked out some of the most important points.

Cadaret Grant acquired by private-equity-backed Atria

75-year-old owner Arthur Grant positions the IBD for the 'next 33 years.'

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print